Stock CBIH CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cannabis Bioscience International Holdings, Inc.

Equities

CBIH

US16948K1060

Delayed OTC Markets
Other stock markets
 12:53:44 2024-07-12 pm EDT 		5-day change 1st Jan Change
0.00085 USD -5.56% Intraday chart for Cannabis Bioscience International Holdings, Inc. 0.00% +12.50%
Jun. 26 Cannabis Bioscience International Holdings, Inc. Appoints John Jones as Treasurer and Director CI
Jun. 05 CBIH and VITA Biotech Research Forge Alliance to Propel Clinical Studies Forward CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine
NE
CBIH Charts Path to Future Leadership in Cannabis Medicine
AQ
CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments
NE
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
AQ
Cannabis Bioscience International Holdings, Inc. Appoints John Jones as Treasurer and Director
CI
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
AQ
CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader
NE
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
AQ
CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment
NE
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
AQ
CBIH and VITA Biotech Research Forge Alliance to Propel Clinical Studies Forward
CI
Vita Biotech Retains CBIH Services for Clinical Studies
NE
Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation
NE
CBIH Engages Prestigious Law Firm for its First Patent Applications
NE
CBIH Welcomes New Treasurer and Director, Mr. John E. Jones
NE
Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024
CI
CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"
NE
Cannabis Bioscience International Holdings, Inc. announced that it has received $0.05 million in funding from 1800 Diagonal Lending, LLC
CI
Cannabis Bioscience International Holdings, Inc. announced that it expects to receive $0.05 million in funding from 1800 Diagonal Lending, LLC
CI
CBIH Announces the Retirement of One Billion Shares
NE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBIH Stock
  4. News Cannabis Bioscience International Holdings, Inc.